FDA Asks Teva For More Info On New Huntington's Drug
The U.S. Food and Drug Administration wants more answers from Teva Pharmaceutical Industries regarding certain blood byproducts created by its breakthrough treatment for a symptom of Huntington's disease before the agency...To view the full article, register now.
Already a subscriber? Click here to view full article